Free Trial

Corvus Pharmaceuticals (CRVS) Institutional Ownership

Corvus Pharmaceuticals logo
$12.00 +0.26 (+2.21%)
Closing price 04:00 PM Eastern
Extended Trading
$12.14 +0.14 (+1.20%)
As of 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

Current
Institutional Ownership
Percentage
46.64%
Number of
Institutional Buyers
(last 12 months)
81
Total
Institutional Inflows
(last 12 months)
$177.33M
Number of
Institutional Sellers
(last 12 months)
23
Total
Institutional Outflows
(last 12 months)
$36.64M
Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/4/2026 Seven Fleet Capital Management LP82,890$1.21M0.4%N/A0.099%
5/29/2026 Perceptive Advisors LLC2,292,441$33.54M0.7%+231.1%2.726%
5/28/2026 Avidity Partners Management LP115,000$1.68M0.3%N/A0.137%
5/20/2026 Vivo Capital LLC2,805,816$41.05M3.4%+25.6%3.337%
5/18/2026 ADAR1 Capital Management LLC87,901$1.29M0.1%-81.1%0.105%
5/16/2026 The Manufacturers Life Insurance Company 101,779$1.49M0.0%+481.7%0.121%
5/16/2026 Quantinno Capital Management LP22,982$336K0.0%N/A0.027%
5/15/2026 Commodore Capital LP2,258,735$33.05M1.9%N/A2.686%
5/15/2026 Spruce Street Capital LP231,585$3.39M0.8%N/A0.275%
5/14/2026 Renaissance Technologies LLC81,310$1.19M0.0%N/A0.097%
5/14/2026 Sei Investments Co.60,848$890K0.0%N/A0.072%
5/7/2026 SEB Asset Management AB226,837$3.32M0.0%N/A0.270%
5/6/2026 Towerview LLC70,000$1.02M0.7%-50.0%0.083%
5/5/2026 Bank of New York Mellon Corp185,347$2.71M0.0%+40.8%0.220%
5/4/2026 Emerald Mutual Fund Advisers Trust459,253$6.72M0.3%N/A0.546%
5/4/2026 Emerald Advisers LLC686,216$10.04M0.3%N/A0.816%
5/4/2026 Teachers Retirement System of The State of Kentucky8,000$117K0.0%N/A0.010%
4/29/2026 Shelton Wealth Management LLC12,268$179K0.1%-21.6%0.015%
4/28/2026 Whittier Trust Co. of Nevada Inc.10,200$150K0.0%-8.9%0.012%
4/27/2026 Simplify Asset Management Inc.20,242$296K0.0%N/A0.024%
4/16/2026 SG Americas Securities LLC35,420$518K0.0%+76.9%0.042%
3/20/2026 Hsbc Holdings PLC59,269$451K0.0%-28.1%0.071%
2/19/2026 Invesco Ltd.43,583$336K0.0%+12.7%0.052%
2/18/2026 Virtus Investment Advisers LLC31,783$245K0.1%+18.4%0.038%
2/18/2026 Wellington Management Group LLP314,683$2.42M0.0%+74.7%0.376%
2/18/2026 RTW Investments LP447,607$3.45M0.0%-83.3%0.534%
2/18/2026 Perceptive Advisors LLC692,441$5.33M0.1%-51.9%0.827%
2/18/2026 Millennium Management LLC688,770$5.30M0.0%N/A0.822%
2/18/2026 Bridgeway Capital Management LLC26,700$206K0.0%-60.0%0.032%
2/17/2026 Logos Global Management LP500,000$3.85M0.2%N/A0.597%
2/17/2026 ADAR1 Capital Management LLC465,875$3.59M0.3%N/A0.556%
2/17/2026 MPM Bioimpact LLC2,743,671$21.13M2.4%N/A3.275%
2/17/2026 Price T Rowe Associates Inc. MD34,105$263K0.0%+5.2%0.041%
2/17/2026 Captrust Financial Advisors11,051$85K0.0%N/A0.013%
2/17/2026 Fred Alger Management LLC144,381$1.11M0.0%N/A0.172%
2/17/2026 ExodusPoint Capital Management LP86,720$668K0.0%N/A0.104%
2/17/2026 Graham Capital Management L.P.19,274$148K0.0%N/A0.023%
2/17/2026 Foresite Capital Management VI LLC1,381,233$10.64M3.2%-20.2%1.649%
2/16/2026 Squarepoint Ops LLC104,820$807K0.0%N/A0.125%
2/16/2026 Truvestments Capital LLC10,257$79K0.0%+86.1%0.012%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
2/16/2026 Verition Fund Management LLC21,382$165K0.0%N/A0.026%
2/16/2026 Barclays PLC394,766$3.04M0.0%+27.7%0.471%
2/13/2026 Marshall Wace LLP216,248$1.67M0.0%N/A0.258%
2/13/2026 The Manufacturers Life Insurance Company 17,497$135K0.0%-6.6%0.021%
2/13/2026 Rafferty Asset Management LLC99,724$768K0.0%N/A0.119%
2/13/2026 Charles Schwab Investment Management Inc.171,173$1.32M0.0%-3.7%0.204%
2/13/2026 State Street Corp2,788,223$21.47M0.0%+177.1%3.328%
2/13/2026 Wells Fargo & Company MN62,623$482K0.0%+72.1%0.075%
2/12/2026 DRW Securities LLC23,384$180K0.0%N/A0.028%
2/12/2026 MetLife Investment Management LLC30,782$237K0.0%-8.4%0.037%
2/12/2026 Alps Advisors Inc.61,318$472K0.0%N/A0.073%
2/11/2026 DCF Advisers LLC729,000$5.61M1.5%N/A0.870%
2/11/2026 Deutsche Bank AG56,039$432K0.0%+4.5%0.067%
2/11/2026 Fox Run Management L.L.C.11,220$86K0.0%N/A0.013%
2/10/2026 Goldman Sachs Group Inc.553,327$4.26M0.0%+24.2%0.661%
2/10/2026 AXQ Capital LP12,601$97K0.0%-53.4%0.015%
2/10/2026 Intech Investment Management LLC35,973$277K0.0%+37.5%0.043%
2/9/2026 Geode Capital Management LLC1,473,026$11.35M0.0%+1.1%1.758%
2/6/2026 ProShare Advisors LLC13,764$106K0.0%+7.7%0.016%
2/4/2026 Towerview LLC140,000$1.08M0.8%-17.6%0.167%
1/29/2026 China Universal Asset Management Co. Ltd.18,169$140K0.0%+39.1%0.022%
1/26/2026 Shelton Wealth Management LLC15,638$120K0.1%+13.8%0.021%
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,629$28K0.0%+26.0%0.005%
1/21/2026 Palumbo Wealth Management LLC26,255$202K0.0%+11.2%0.035%
1/21/2026 Sowell Financial Services LLC17,000$131K0.0%+41.7%0.023%
1/16/2026 Tema Etfs LLC79,698$614K0.0%+34.6%0.107%
1/16/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management167,400$1.29M0.0%-1.1%0.224%
1/9/2026 SG Americas Securities LLC20,021$154K0.0%N/A0.027%
1/1/2026 JPMorgan Chase & Co.32,232$238K0.0%+6.0%0.043%
11/17/2025 Quarry LP3,653$27K0.0%N/A0.005%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,525$203K0.0%-4.0%0.037%
11/17/2025 Jain Global LLC27,618$204K0.0%N/A0.037%
11/17/2025 Brevan Howard Capital Management LP15,300$113K0.0%N/A0.020%
11/17/2025 Bank of America Corp DE151,966$1.12M0.0%+14.5%0.203%
11/14/2025 Creative Planning25,299$186K0.0%N/A0.034%
11/14/2025 Ancora Advisors LLC47,290$349K0.0%+9.7%0.063%
11/14/2025 Two Sigma Investments LP203,360$1.50M0.0%-9.2%0.272%
11/13/2025 UBS Group AG162,074$1.19M0.0%+80.7%0.217%
11/13/2025 BNP Paribas Financial Markets12,516$92K0.0%+125.9%0.017%
11/13/2025 Russell Investments Group Ltd.6,661$49K0.0%N/A0.009%
11/12/2025 Barclays PLC309,152$2.28M0.0%-10.0%0.414%
11/10/2025 Palumbo Wealth Management LLC23,614$174K0.0%N/A0.032%
11/10/2025 AXQ Capital LP27,051$199K0.1%N/A0.036%
11/10/2025 China Universal Asset Management Co. Ltd.13,061$96K0.0%-15.7%0.017%
11/7/2025 NEOS Investment Management LLC59,202$436K0.0%N/A0.079%
11/7/2025 GSA Capital Partners LLP401,407$2.96M0.2%+25.9%0.538%
11/7/2025Vanguard Group Inc.3,471,925$25.59M0.0%+5.8%4.649%
11/7/2025 JPMorgan Chase & Co.32,232$238K0.0%+6.0%0.043%
11/6/2025 Rhumbline Advisers82,590$609K0.0%+8.7%0.111%
11/3/2025 New York State Common Retirement Fund18,800$139K0.0%-21.0%0.025%
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
10/20/2025Masso Torrence Wealth Management Inc.17,000$125K0.1%-66.0%0.023%
10/9/2025 Shelton Wealth Management LLC13,742$101K0.0%N/A0.018%
8/28/2025 China Universal Asset Management Co. Ltd.15,488$62K0.0%+20.2%0.021%
8/27/2025 Squarepoint Ops LLC138,462$554K0.0%+37.0%0.186%
8/15/2025 Sender Co & Partners Inc.12,995$52K0.0%N/A0.017%
8/15/2025 Perceptive Advisors LLC1,438,595$5.75M0.5%N/A1.931%
8/15/2025 Bridgeway Capital Management LLC66,700$267K0.0%+61.5%0.090%
8/15/2025 Bank of America Corp DE132,729$531K0.0%+34.7%0.178%
8/14/2025 Orbimed Advisors LLC7,165,006$28.66M0.8%+3.2%9.616%
8/14/2025 Jane Street Group LLC10,118$40K0.0%-96.2%0.014%


CRVS Institutional Ownership - Frequently Asked Questions

During the previous two years, 118 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Vivo Capital LLC ($41.05M), Perceptive Advisors LLC ($33.54M), Commodore Capital LP ($33.05M), Orbimed Advisors LLC ($28.66M), Vanguard Group Inc. ($25.59M), State Street Corp ($21.47M), and MPM Bioimpact LLC ($21.13M).Learn more on Corvus Pharmaceuticals' institutional investors.

46.64% of Corvus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Of the 110 institutional investors that purchased Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($5.96M), Samlyn Capital LLC ($3.77M), Perceptive Advisors LLC ($3.04M), MPM Bioimpact LLC ($2.74M), RTW Investments LP ($2.68M), Commodore Capital LP ($2.26M), and State Street Corp ($1.84M).

Institutional investors have bought a total of 18,800,207 shares in the last 24 months. This purchase volume represents approximately $177.33M in transactions.

Of the 23 institutional investors that sold Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($2.23M), Perceptive Advisors LLC ($746.15K), Qube Research & Technologies Ltd ($405.11K), ADAR1 Capital Management LLC ($377.97K), Foresite Capital Management VI LLC ($350K), Jane Street Group LLC ($256.79K), and Towerview LLC ($100K).

Institutional investors have sold a total of 4,686,953 shares in the last 24 months. This volume of shares sold represents approximately $36.64M in transactions.



This page (NASDAQ:CRVS) was last updated on 6/17/2026 by MarketBeat.com Staff.
From Our Partners